CorMedix Inc expected to post a loss of 20 cents a share - Earnings Preview

CorMedix

08/03/2024 13:04

* CorMedix Inc  CRMD.OQ   CRMD.O  is expected to show a fall
in
quarterly revenue when it reports  results on March 12 for the
period ending December 31 2023
    * The Berkeley Heights New Jersey-based  company is expected
to
report a 962.1% decrease in revenue to $-250 thousand from $29
thousand a year ago, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for CorMedix Inc is for a
loss
of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CorMedix
Inc is
$12.00​, above​ its last closing price of $3.62. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.20       -0.21      -0.17     Beat    18.2
 Jun. 30 2023  -0.23       -0.24      -0.25     Missed  -3.6
 Mar. 31 2023  -0.20       -0.20      -0.24     Missed  -20​
 Dec. 31 2022              -0.19      -0.20     Missed  -7
 ​​Sep.        -0.22       -0.23      -0.17     Beat    25.5
 30 2022                                                
 Jun. 30 2022  -0.20       -0.21      -0.19     Beat    8.1​
 Mar. 31 2022  -0.22       -0.22      -0.18     Beat    18.2
 Dec. 31 2021              -0.23      -0.20     Beat    14.3
 This summary was machine generated March 8 at 13:04 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)